The device, developed by Medelpharm, encapsulates the cores within a shell made of one or two different blends, opening up a wide range of new applications.
The device can also position 2 cores within a single tablet shell. Press Coating prototypes with 1 or 2 cores, can now be automatically manufactured at early R&D development stages or Phase II clinical batches (GMP software).
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.